Decrement Evoked Potential (DEEP) Mapping of the Atria: Unmasking Atrial Fibrillation Substrate
Atrial myopathy may underlie the progression of atrial fibrillation (AF) from a treatable disease to an irreversible condition with poor ablation outcomes. Electrophysiological methods to unmask areas prone to re-entry initiation could be key to defining latent atrial myopathy. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - August 25, 2023 Category: Cardiology Authors: Oscar Salvador Monta ñés, John L. Fitzgerald, Nicholas Jackson, Shouvik Haldar, Haseeb Valli, Josh Cotton, Gwilym M. Morris, Sigfus Gizurarson, José Angel Cabrera, Kumaraswamy Nanthakumar, Andreu Porta-Sánchez Tags: Original Article Source Type: research
Interrelation of Chronic Lung Disease and Cardiovascular Disease Based on Two National Prospective Cohort Studies
This study aimed to estimate the interrelation of CLDs and CVDs using two Chinese national longitudinal cohort studies. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - August 12, 2023 Category: Cardiology Authors: Xueling Ren, Shengshu Wang, Junsong Lian, Chunjiang Pan, Baobao Li, Yan He, Jing Zhao, Dan Wang, Zheng Luo, Jiangqiong Shen, Zhifeng Sun, Yanka Hou, Lin Qi, Qian Lu, Ping Lv, Yuling Wang, Qinge Yong Tags: Original Article Source Type: research
Interrelation of Chronic Lung Disease and Cardiovascular Disease: Based on Two National Prospective Cohort Studies
This study aimed to estimate the interrelation of CLDs and CVDs using two Chinese national longitudinal cohort studies. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - August 12, 2023 Category: Cardiology Authors: Xueling Ren, Shengshu Wang, Junsong Lian, Chunjiang Pan, Baobao Li, Yan He, Jing Zhao, Dan Wang, Zheng Luo, Jiangqiong Shen, Zhifeng Sun, Yanka Hou, Lin Qi, Qian Lu, Ping Lv, Yuling Wang, Qinge Yong Tags: Original Article Source Type: research
Cardiovascular Disease in Patients With Breast Cancer Treated in the Modern Era
With improving cancer survivorship, cardiovascular disease (CVD) has become a leading cause of death in breast cancer (BC) survivors. At present, there is no prospectively validated, contemporary risk assessment tool specific to this patient cohort. Accordingly, we sought to investigate long-term cardiovascular outcomes in early-stage BC patients utilising a well characterised database at a quaternary referral centre. With the assembly of this cohort, we have derived a BC cardiovascular risk index titled the ‘CRIB (Cardiovascular Risk Index in Breast Cancer)’ to estimate the risk of a major adverse cardiovascular event...
Source: Heart, Lung and Circulation - August 11, 2023 Category: Cardiology Authors: Alexandra C. Murphy, Anoop N. Koshy, Omar Farouque, Belinda Yeo, Laura Roccisano, Yanti Octavia, Matias B. Yudi Tags: Original Article Source Type: research
Associations Between Atherosclerosis and Elevated Serum Alkaline Phosphatase in Patients With Coronary Artery Disease in an Inflammatory State
This study investigated the relationship between serum ALP and atherosclerosis in patients with coronary artery disease (CAD) in an inflammatory state. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - August 5, 2023 Category: Cardiology Authors: Ziqin Lai, Yijia Liu, Mengnan Huang, Lin Li, Zhu Li, Jinyu Su, Guangwei Pan, Bin Li, Shan Gao, Chunquan Yu Tags: Original Article Source Type: research
Emerging Roles of Artificial Intelligence (AI) in Cardiology: Benefits and Barriers in a ‘Brave New World’
‘We can't allow science to undo its own good work.’Aldous Huxley, Brave New World, 1932 (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - August 4, 2023 Category: Cardiology Authors: Nicole K. Bart, Salvatore Pepe, Ann T. Gregory, A. Robert Denniss Tags: Editorial Source Type: research
Aligning Guidelines and Practice: The Monitoring of Cardiovascular Implantable Electronic Devices in Australia and New Zealand
In June 2022, the Cardiac Society of Australia and New Zealand (CSANZ) released a position statement on the follow-up of cardiovascular implantable electronic devices [1]. Subsequently, in May 2023, the Heart Rhythm Society (in collaboration with the European Heart Rhythm Association [EHRA], the Latin American Heart Rhythm Society [LAHRS], and our local electrophysiology society, the Asia Pacific Heart Rhythm Society [APHRS] – albeit without an Australian representative) published an expert consensus statement on the practical management of remote device clinics [2]. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - August 3, 2023 Category: Cardiology Authors: Bradley Wilsmore, Haris Haqqani Tags: Editorial Source Type: research
Association of Hospital Volume and Outcomes Following Off-Pump Coronary Artery Bypass Grafting
Off-pump coronary artery bypass grafting (OPCAB) has been used to mitigate the negative systemic effects of cardiopulmonary bypass. Recent consortium and single-institution studies suggest an association between operator experience and long-term survival. We thus aimed to ascertain the relationship between institutional OPCAB volume and outcomes using a contemporary nationwide all-payer database. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - August 2, 2023 Category: Cardiology Authors: Nikhil Chervu, Arjun Verma, Sara Sakowitz, Syed Shahyan Bakhtiyar, Joseph Hadaya, Yas Sanaiha, Peyman Benharash Tags: Original Article Source Type: research
Refining Automated External Defibrillator Signage to Improve Out-of-Hospital Cardiac Arrest Survival
Public-access automated external defibrillators (AEDs) are crucial in situations of out-of-hospital cardiac arrest (OHCA), with time to these devices being located being directly associated with patient survival. Previous studies have examined evidence-based strategies regarding the strategic placement of public AEDs [1]. A deliberate evidence-based approach to the design, colour, and content of signage is required to enable rapid public-access. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - August 1, 2023 Category: Cardiology Authors: Joshua G. Kovoor, Stephen Bacchi, Aashray K. Gupta, Brandon Stretton, Gregory J. Page, Pramesh Kovoor Tags: Letter to the Editor Source Type: research
Letter to the Editor Regarding Erythropoietin-Stimulating Agents Resistance in Haemodialysis-Treated Patients: Time for a Treatment Shift?
The incidence of chronic kidney disease (CKD) is increasing worldwide, and the current prevalence rate is about 8% –16% [1]. More than half a million adults in the USA have CKD requiring dialysis treatment and>90% of patients on dialysis have anaemia, leading to increased morbidity and mortality. Traditional treatment for renal anaemia includes iron agents and erythropoiesis-stimulating agents (ESAs). Responsiveness to ESAs is associated with increased cardiovascular disease (CVD) risk and mortality in patients undergoing haemodialysis (HD). (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - August 1, 2023 Category: Cardiology Authors: Roberto G. Carbone, Simone Negrini, Francesco Puppo Tags: Letter to the Editor Source Type: research
Back to Nature ’s Way: Pacing the Conducting System
Pacing has undergone significant evolution over the past century from external pacemakers introduced in the late 1920s to totally implantable pacemakers in the late 1950s. The quest to attain optimal ventricular synchronisation has led to newer techniques of biventricular pacing in the 1990s and, more recently, conduction system pacing (CSP). The desire for cardiac physiologic pacing stems from the known deleterious effects of pacing-induced ventricular dyssynchony from conventional right ventricular pacing, including development of cardiomyopathy, increased risk of atrial fibrillation, heart failure hospitalisations, and ...
Source: Heart, Lung and Circulation - August 1, 2023 Category: Cardiology Authors: Dennis H. Lau, Suraya H. Kamsani, Uwais Mohamed, Jai Raman Tags: Editorial Source Type: research
Risks and Burdens of Unplanned Heart Failure Readmissions: How to Cut a Gordian Knot?
Heart failure admission reflects an adverse inflection point for a patient ’s clinical journey with substantially increased risks of morbidity and mortality, even after successful decongestion. It has been estimated that 20% of acute heart failure patients will be readmitted to hospital within 30 days of discharge and 50% will be readmitted at 6 months, indicating that this subpopulation represents an inherently high-risk group [1]. It is possible that a quarter of these readmissions could be preventable, which would represent a significant public health advancement if achieved [2]. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - August 1, 2023 Category: Cardiology Authors: Mark Nolan, Clare Arnott Tags: Editorial Source Type: research
Heart Foundation ’s blood pressure resources
Victoria Leitch BSci(Biomed), MScC, PhD (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - August 1, 2023 Category: Cardiology Source Type: research
Editorial Board
(Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - August 1, 2023 Category: Cardiology Source Type: research
Cardiac Society of Australia and New Zealand
(Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - August 1, 2023 Category: Cardiology Source Type: research
